128427-05-4

Usage

Uses

Used in Pharmaceutical Industry:
(S)-2-ETHYL-PIPERAZINE-2HCl is used as a building block for the synthesis of various pharmaceuticals, particularly in the development of antipsychotic and anti-inflammatory drugs, due to its versatile chemical properties and ability to enhance the therapeutic effects of these medications.
Used in Anti-cancer Research:
(S)-2-ETHYL-PIPERAZINE-2HCl is used as a potential anti-cancer agent, being investigated for its ability to target and inhibit the growth of cancer cells, offering a promising avenue for the development of novel cancer therapies.
Used in Medical Imaging:
(S)-2-ETHYL-PIPERAZINE-2HCl is used as a component in medical imaging, leveraging its chemical properties to improve the contrast and clarity of imaging techniques, thereby aiding in the diagnosis and monitoring of various diseases.
Used in Drug Delivery Systems:
(S)-2-ETHYL-PIPERAZINE-2HCl is used as a component in drug delivery systems to enhance the efficacy and targeted delivery of pharmaceuticals, improving their bioavailability and therapeutic outcomes.

Upstream product

• 325145-35-5 (S)-2-ethylpiperazine-1-carboxylic acid tert-butyl ester 
• 393781-70-9 (R)-2-ethylpiperazine-1-carboxylic acid tert-butyl ester 
• 347195-55-5 (R)-1-benzyl-3-ethylpiperazine 

Downstream Products

• 438049-35-5 3-ethylpiperazine-1-carboxylic acid tert-butyl ester 
• 438050-08-9 tert-butyl (3R)-3-ethylpiperazine-1-carboxylate 

Relevant academic research and scientific papers

MORPHOLINOPURINE DERIVATIVES

There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.

5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION

This invention relates to compounds of formula (I).

Novel piperazine derivatives

The present invention is a chemical compound of formula (I) or a pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4, A1, A2 m and n are as described in the specification.

NOVEL SULFONYL DERIVATIVES

Sulfonyl derivatives represented by the following general formula (I): Q1-Q2-T1-Q3-SO2-QA and drugs containing the same (wherein Q1 is an optionally substituted, saturated or unsaturated, five- or six-membered cyclic hydrocarbon group, a five- or six-membered heterocyclic group, or the like; Q2 is a single band, oxygen, sulfur, C1-C6 alkylene or the like; QA is optionally substituted arylalkenyl, heteroarylalkenyl or the like; and T1 is carbonyl or the like). These compounds have potent FXa-inhibitory effects and promptly exert satisfactory and persistent antithrombotic effects through oral administration, thus being useful as anticoagulant agents little accompanied with side effects.